Physitrack: Q2’25 Interview with CEO Henrik Molin
25 juli, 07:15
25 juli, 07:15
In this interview, we speak with Physitrack’s CEO following a strong Q2 marked by margin expansion and positive free cash flow. We discuss the drivers behind the company’s 21% ARR growth, the evolving business model within Wellness, and the outlook for sustaining growth. With adjusted EBITDA margin reaching 33% and reinvestment capacity improving, we also touch on where the company sees the next wave of strategic opportunities—both geographically and across its platform offering.
25 juli, 07:15
In this interview, we speak with Physitrack’s CEO following a strong Q2 marked by margin expansion and positive free cash flow. We discuss the drivers behind the company’s 21% ARR growth, the evolving business model within Wellness, and the outlook for sustaining growth. With adjusted EBITDA margin reaching 33% and reinvestment capacity improving, we also touch on where the company sees the next wave of strategic opportunities—both geographically and across its platform offering.
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
1 DAG %
Senast
Kempower
Igår, 12:28
Laddat för tillväxt i Kempower
OMX Stockholm 30
1 DAG %
Senast
2 533,59